LSK Technologies provides a low-cost diagnostic platform that utilizes nucleic acid testing and advanced camera vision technology to deliver results for COVID-19 and other diseases within 30 minutes. This solution enables high-throughput testing with real-time result access, addressing the need for rapid and affordable diagnostics in various healthcare settings.
Funding
$199.7K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
FRUVFounders
Product
Problem
Traditional laboratory-based nucleic acid testing for viral and antibody detection often requires specialized equipment, trained personnel, and complex logistics, leading to delays and increased costs. This can limit access to rapid and accurate diagnostics, particularly in point-of-care settings like pharmacies and remote locations.
Solution
LSK Technologies offers a low-cost, high-throughput diagnostic platform that enables rapid nucleic acid testing for various diseases, including COVID-19. The platform combines advanced camera vision technology with molecular kits to quantitatively analyze optical reactions, delivering results in approximately 30 minutes. This solution provides real-time access to results and simplifies logistics, making lab-quality testing accessible in diverse settings. The platform is available in configurations suited for both laboratory and pharmacy environments, offering scalable solutions for viral and antibody detection.
Target Audience
The primary target audiences include laboratories seeking high-throughput viral and antibody detection, as well as pharmacies looking for scalable, point-of-care testing solutions.
Features
- High-throughput plate reader for viral and antibody detection in a multimode format
- Molecular kits optimized for use with the plate reader
- Scalable plug-and-play testing solution designed for pharmacy settings
- PCR-equivalent test results at the speed of an antigen test
- Advanced camera vision technology for quantitative analysis of optical reactions
- Real-time access to test results